Aggressive behaviour in dementia and its pharmacologic treatment: A review

References

• Diagnostic and statistical manual of mental disorders III, revised version. APA, Washington, DC 1987
   Google Scholar
• Burns A, Jacoby R, Levy R. Psychiatric disorders in Alzheimer's disease. I. Disorders of thought content. Br J Psychiatry 1990; 157: 72–6
   PubMed Web of Science ®Google Scholar
• Burns A, Jacoby R, Levy R. Psychiatric phenomena in Alzheimer's disease. II. Disorders of perception. Br J Psychiatry 1990; 157: 76–81
   PubMed Web of Science ®Google Scholar
• Burns A, Jacoby R, Levy R. Psychiatric phenomena in Alzheimer's disease. III. Disorders of mood. Br J Psychiatry 1990; 157: 81–6
   PubMed Web of Science ®Google Scholar
• Skoog I. The prevalence of psychotic, depressive and anxiety syndromes in demented and non-demented 85-year-olds. Int J Ger Psych 1993; 8: 247–54
   Web of Science ®Google Scholar
• Patel V, Hope R A. Aggressive behaviour in the elderly psychiatric inpatients. Acta Psych Scand 1992; 85: 131–5
   PubMed Web of Science ®Google Scholar
• Patel V, Hope R A. Aggressive behaviour in elderly people with dementia: a review. Int J Ger Psychiatry 1993; 8: 457–72
   Web of Science ®Google Scholar
• Sultzer D L, Levin H S, Mahler M E, High W M, Cummings J L. A comparison of psychiatric symptoms in vascular dementia and Alzheimer's disease. Am J Psychiatry 1993; 150: 1806–12
   PubMed Web of Science ®Google Scholar
• Rabins P V, Mace N L, Lucas M J. The impact of dementia on the family. JAMA 1982; 248: 333–5
   PubMed Web of Science ®Google Scholar
• Nygaard H A. Strain on caregivers of demented elderly people living at home. Scand J Prim Health Care 1988; 6: 33–7
   PubMedGoogle Scholar
• Steele C, Rovner B, Chase B A, Folstein M. Psychiatric symptoms and nursing home placement of patients with Alzheimer's disease. Am J Psychiatry 1990; 147: 1049–51
   PubMed Web of Science ®Google Scholar
• Nygaard H A. Who cares for the caregiver? Factors exerting influence on nursing home admissions of demented elderly. Scand J Caring Sci 1991; 5: 157–62
   PubMedGoogle Scholar
• Aronson M K, Post D C, Guastadisegni P. Dementia, agitation, and care in the nursing home. J Am Ger Soc 1993; 41: 507–12
   PubMed Web of Science ®Google Scholar
• Cohen-Mansfield J. Agitated behaviors in the elderly. II. Preliminary results in the cognitively deteriorated. J Am Ger Soc 1986; 34: 722–7
   PubMed Web of Science ®Google Scholar
• Patel V, Hope R A. A rating scale for aggressive behaviour in the elderly — the RAGE. Psychol Med 1922; 22: 211–21
   Google Scholar
• Cohen-Mansfield J, Marx M S. The relationship between depression and agitation in nursing home residents. Compr Gerontol 1988; 2: 141–6
   PubMedGoogle Scholar
• Jeste D V, Wragg R E, Salmon D P, Harris J M, Thal L. Cognitive deficits of patients with Alzheimer's disease with and without delusions. Am J Psychiatry 1992; 149: 184–9
   PubMed Web of Science ®Google Scholar
• Cooper J K, Mungas D, Weiler P. Relation of cognitive status and abnormal behaviours in Alzheimer's disease. J Am Ger Soc 1990; 38: 867–70
   PubMed Web of Science ®Google Scholar
• Kurita A, Blass J P, Nolan K A, Black R S, Thaler H T. Relationship between cognitive status and behavioral symptoms in Alzheimer's disease and mixed dementia. J Am Ger Soc 1993; 41: 732–6
   PubMed Web of Science ®Google Scholar
• Deutsch L H, Bylsma F W, Rovner B W, Steele C, Folstein M F. Psychosis and physical aggression in probable Alzheimer's disease. Am J Psychiatry 1991; 148: 1159–63
   PubMed Web of Science ®Google Scholar
• Lopez O L, Becker J T, Brenner R P, Rosen J, Bajulaiye O I. Reynolds C Alzheimer F.'s disease with delusions and hallucinations. Neurology 1991; 41: 906–12
   PubMed Web of Science ®Google Scholar
• Baldwin R C. Depressive illness. Psychiatry in the elderly, R Jacoby, C Oppenheimer. Oxford University Press, Oxford 1991; 656–719
   Google Scholar
• Ryden M B. Aggressive behavior in persons with dementia (abstract). Gerontologist 1986; 26: 228A, (Spec Iss)
   Web of Science ®Google Scholar
• Negley E N, Manley J T. Environmental interventions in assaultive behavior. J Geront Nurs 1990; 16: 29–33
   PubMedGoogle Scholar
• Hamel M, Gold D P, Andres D, Reis M, Dastoor D, Grauer H, et al. Predictors and consequences of aggressive behavior by community-based dementia patients. Gerontologist 1990; 30: 206–11
   PubMed Web of Science ®Google Scholar
• O'Connor M. Disturbed behaviour in dementia — psychiatric or medical problem?. Med J Austr 1987; 147: 481–5
   PubMed Web of Science ®Google Scholar
• Malone M, Thompson L, Goodwin J S. Aggressive behaviours among the institutionalized elderly. J Am Ger Soc 1993; 41: 853–6
   PubMed Web of Science ®Google Scholar
• Corrigan P W, Yudofsky S C, Silver J M. Pharmacological and behavioral treatments for aggressive psychiatric inpatients. Hosp Com Psychiatry 1993; 44: 125–33
   PubMedGoogle Scholar
• Teri L, Rabins P, Whitehouse P, Berg L, Reisberg B, Sunderland T, et al. Management of behavior disturbance in Alzheimer's disease: current knowledge and future directions. Alz Dis Ass Disord 1992; 6: 77–88
   PubMed Web of Science ®Google Scholar
• Davis K L, Kahn R S, Ko G, Davidson M. Dopamine in schizophrenia: a review and reconceptualization. Am J Psychiatry 1991; 148: 1474–86
   PubMed Web of Science ®Google Scholar
• Seeman P. Dopamine receptor sequences. Therapeutic levels of neuroleptics occupy D2 receptors, clozapine occupies D4. Neuropsychopharmacology 1992; 7: 261–84
   PubMed Web of Science ®Google Scholar
• Zubenko G S, Moossy J, Martinez J, Rao A J, Claassen D, Rosen J, et al. Neuropathologic and neuro-chemical correlates of psychosis in primary dementia. Arch Neurol 1991; 48: 619–24
   PubMed Web of Science ®Google Scholar
• Mulsant B H, Gershon S. Neuroleptics in the treatment of psychosis in late life: a rational approach. Int J Ger Psychiatry 1993; 8: 979–92
   Web of Science ®Google Scholar
• Perry E K. The cholinergic hypothesis — ten years on. Br Med Bull 1986; 42: 63–9
   PubMed Web of Science ®Google Scholar
• Hyman S E, Nestler E J. The molecular foundations of psychiatry. APA, Washington, DC 1993
   Google Scholar
• Coccaro E F. Central serotonin and impulsive aggression. Br J Psychiatry 1989; 155(Suppl)52–62
   Google Scholar
• Palmer A M, Stratmann G C, Procter A W, Bowen D M. Possible neurotransmitter basis of behavioral changes in Alzheimer's disease. Ann Neurol 1988; 23: 616–20
   PubMed Web of Science ®Google Scholar
• Whitford G M. Alzheimer's disease and serotonin. A review. Neuropsychobiology 1986; 15: 133–42
   PubMed Web of Science ®Google Scholar
• Schneider L S, Severson J A, Chui H C, Pollock V E, Sloane R B, Fredrickson E R. Platelet tritiated imipramine binding and MAO activity in Alzheimer's patients with agitation and delusions. Psychiat Res 1988; 25: 311–22
   PubMed Web of Science ®Google Scholar
• Zubenko G S, Moossy J, Kopp U. Neurochemical correlates of major depression in primary dementia. Arch Neurol 1990; 47: 209–14
   PubMedGoogle Scholar
• Eichelman B. Towards a rational pharmacotherapy for aggressive and violent behavior. Hosp Com Psychiatry 1988; 39: 31–9
   PubMedGoogle Scholar
• Cohen-Mansfield J, Billig N. Agitated behaviors in the elderly. I. A conceptual review. J Am Ger Soc 1986; 34: 711–21
   PubMed Web of Science ®Google Scholar
• Shader R I, Harmatz J S, Salzman C. A new scale for clinical assessment in geriatric populations. J Am Ger Soc 1974; 22: 107–13
   PubMed Web of Science ®Google Scholar
• Rosen W G, Mohs R C, Davis K L. A new rating scale for Alzheimer's disease. Am J Psychiatry 1984; 141: 1356–64
   PubMed Web of Science ®Google Scholar
• Gottfries C G, Bråne G, Steen G. A new rating scale for dementia syndromes. Arch Gerontol Geriatr 1982; 1: 311–30
   PubMedGoogle Scholar
• Bucht G, Adolfsson R. The Comprehensive Psychopathological Rating Scale in patients with dementia. Acta Psych Scand 1983; 68: 263–70
   PubMed Web of Science ®Google Scholar
• Sultzer D L, Levin H S, Mahler M E, High W M, Cummings J L. Assessment of cognitive, psychiatric and behavioral disturbances in patients with dementia: the Neurobehavioral Rating Scale. J Am Ger Soc 1992; 40: 549–55
   PubMed Web of Science ®Google Scholar
• Cummings J L, Mega M, Gray K, Rosenberg-Thompson S, Carusi D A, Gornbein J. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology, In press
   Web of Science ®Google Scholar
• Yudofsky S C, Silver J, Hales R E. The Overt Aggression Scale for the objective rating of verbal and physical aggression. Am J Psychiatry 1986; 143: 35–9
   PubMed Web of Science ®Google Scholar
• Palmstierna T, Wistedt B. The Staff Observation Aggression Scale: presentation and evaluation. Acta Psych Scand 1987; 76: 657–63
   PubMed Web of Science ®Google Scholar
• Finkel S I, Lyons J S, Anderson R L. A brief agitation rating scale (BARS) for nursing home elderly. J Am Ger Soc 1993; 41: 50–2
   PubMed Web of Science ®Google Scholar
• Lohr J B, Jeste D V, Harris J, Salzman C. Treatment of disordered behavior. Clinical geriatric psychopharmacology. 2nd ed, C Salzman. Williams & Wilkins, Baltimore 1992; 79–114
   Google Scholar
• Schneider L S, Pollock V E, Lyness S A. A metaanalysis of controlled trials of neuroleptic treatment in dementia. J Am Ger Soc 1990; 38: 553–63
   PubMed Web of Science ®Google Scholar
• Carlyle W, Ancill R J, Sheldon L. Aggression in the demented patient: a double-blind study of loxapine versus haloperidol. Int Clin Psychopharmacol 1993; 8: 103–8
   PubMed Web of Science ®Google Scholar
• Harris M J, Panton D, Caliguri M P, Krull A J, Tran-Johnson T K, Jeste D V. High incidence of tardive dyskinesia in older outpatients on low doses of neuroleptics. Psychopharm Bull 1992; 28: 87–92
   PubMedGoogle Scholar
• Salz B L, Kane J M, Woerner M G, Lieberman J A, Alvir J MJ, Blank K, et al. Prospective study of tardive dyskinesia in the elderly. Psychopharm Bull 1989; 25: 52–6
   PubMedGoogle Scholar
• Howard R, Levy R. Depot antipsychotic medication in the management of behavioural and psychotic symptoms in dementia?. Int J Ger Psychiatry 1993; 8: 111–3
   Web of Science ®Google Scholar
• Oberholzer A F, Hendriksen C, Monsch A U, Heierli B, Stahelin H B. Safety and effectiveness of low-dose clozapine in psychogeriatric patients: a preliminary study. Int Psychogeriatr 1992; 4: 187–95
   PubMedGoogle Scholar
• Lee H, Cooney J M, Lawlor B. The use of risperidone, an atypical neuroleptic, in Lewy body disease. Int J Ger Psychiatry 1994; 9: 415–7
   Web of Science ®Google Scholar
• Schneider L S, Sobin P B. Non-neuroleptic medications in the management of agitation in Alzheimer's disease and other dementia: a selective review. Int J Ger Psychiatry 1991; 6: 691–708
   Web of Science ®Google Scholar
• Knapp M J, Knopman D S, Solomon P R, Pendlebury W W, Davis C S, Gracon S I. A 30-week randomized controlled trial of high dose tacrine in patients with Alzheimer's disease. JAMA 1994; 271: 985–91
   PubMed Web of Science ®Google Scholar
• Gorman D G, Read S, Cummings J L. Cholinergic therapy of behavioral disturbances in Alzheimer's disease. Neuropsychiatry Neuropsychol Behav Neurol 1993; 6: 229–34
   Google Scholar
• Nyth A L, Gottfries C G. The clinical efficacy of citalopram in treatment of emotional disturbances in dementia disorders. A nordic multicentre study. Br J Psychiatry 1990; 157: 894–901
   PubMed Web of Science ®Google Scholar
• Colenda C C. Buspirone in treatment of agitated demented patient. Lancet 1988; 2: 1169
   Google Scholar
• Tiller J WG, Dakis J A, Shaw J M. Short-term buspirone treatment in disinhibition with dementia. Lancet 1988; 2: 510
   PubMed Web of Science ®Google Scholar
• Lawlor B A, Radcliffe J, Molchan S E, Martinez R A, Hill J L, Sunderland T. A pilot placebo-controlled study of trazodone and buspirone in Alzheimer's disease. Int J Ger Psychiatry 1994; 9: 55–9
   Web of Science ®Google Scholar
• Greendyke R M, Schuster D B, Wooton J A. Propranolol in the treatment of assaultive patients with organic brain disease. J Clin Psychopharm 1984; 4: 282–5
   PubMed Web of Science ®Google Scholar
• Greendyke R M, Kanter D R, Schuster D B, Verstreate S, Wooton J. Propranolol treatment of assaultive patients with organic brain disease. J Nerv Ment Dis 1986; 174: 290–4
   PubMed Web of Science ®Google Scholar
• Greendyke R M, Kantor D R. Therapeutic effects of pindolol on behavioral disturbances associated with organic brain disease: a double blind study. J Clin Psychiatry 1986; 47: 423–6
   PubMed Web of Science ®Google Scholar
• Weiler P G, Mungas D, Bernick P. propranolol for the control of disruptive behavior in senile dementia. J Ger Psychiatry Neurol 1988; 1: 226–30
   PubMedGoogle Scholar
• Yudofsky S C, Silver J M, Hales R E. Pharmacologic management of aggression in the elderly. J Clin Psychiatry 1990; 51(10)22–8, (Suppl)
   PubMedGoogle Scholar
• Stern R G, Duffelmeyer M E, Zemishlany Z, Davidson M. The use of benzodiazepines in the management of behavioral symptoms in demented patients. Psychiatr Clin N Am 1991; 14: 375–84
   PubMed Web of Science ®Google Scholar
• Coccaro E F, Kramer E, Zemihlany Z, Thorne A, Rice M, III, Giordani B, et al. Pharmacologic treatment of noncognitive behavioral disturbance in elderly demented patients. Am J Psychiatry 1990; 147: 1640–5
   PubMedGoogle Scholar
• Risse S C, Barnes R. Pharmacological treatment of agitation associated with dementia. J Am Ger Soc 1986; 34: 368–76
   PubMed Web of Science ®Google Scholar
• Smith D A, Perry P J. Nonneuroleptic treatment of disruptive behavior in organic mental syndromes. Ann Pharmacother 1992; 26: 1400–8
   PubMed Web of Science ®Google Scholar
• Salzman C. Treatment of anxiety. Clinical geriatric psychopharmacology. 2nd ed, C Salzman. Williams & Wilkins, Baltimore 1992; 189–212
   Google Scholar
• Cook P J. Benzodiazepine hypnotics in the elderly. Acta Psychiatr Scand 1986; 74(Suppl 332)149–58
   Web of Science ®Google Scholar
• Dale P G. Lithium therapy in aggressive mentally subnormal patients. Br J Psychiatry 1980; 137: 469–74
   PubMed Web of Science ®Google Scholar
• Holton A, George K. The use of lithium in severely demented patients with behavioural disturbance. Br J Psychiatry 1985; 146: 99–100
   PubMed Web of Science ®Google Scholar
• Janicak P G, Davis J M, Preskorn S H, Ayd F J. Principles and practice of psychopharmacotherapy. Williams & Wilkins, Baltimore 1993; 343–9
   Google Scholar
• Gleason R P, Schneider L S. Carbamazepien treatment of agitation in Alzheimer's outpatients refractory to neuroleptics. J Clin Psychiatry 1990; 51: 115–8
   PubMed Web of Science ®Google Scholar
• Patterson J F. Carbamazepine for assaultive patients with organic brain disease. Psychosomatics 1988; 28: 579–81
   Web of Science ®Google Scholar
• Chambers C A, Bain J, Rosbottom, Ballinger B R, McLaren S. Carbamzepine in senile dementia and overactivity — placebo controlled double blind trial. IRCS Med Sci 1982; 10: 505–6
   Google Scholar
• Post R M, Weiss S RB, Ketter T A, George M S, Clark M, Rosen J. The temporal lobe and the limbic system. Petersfield. Wrightson Biomed Publ. 1992; 247–66, The temporal lobe and affective disorders, Trimble MR, Bolwig TG
   Google Scholar
• Pippenger C E. Pharmacodynamics of antiepileptic drugs. Clinical use of anticonvulsants in psychiatric disorders, R M Post, M R Trimble, C E Pippenger. Demos Publications, New York 1989; 89–98
   Google Scholar
• Yang J D, Elphick M, Sharpley A L, Cowen P J. Effects of carbamzepine on sleep in healthy volunteers. Biol Psychiatry 1989; 26: 324–8
   PubMed Web of Science ®Google Scholar
• The Parkinson's Study Group. Effect of deprenyl on the progression of disability in early Parkinson's disease. N Engl J Med 1989; 126: 47–54
   Google Scholar
• Tariot P N, Cohen R M, Sunderland T, Newhouse P A, Yount D, Mellow A M, et al. L-Deprenyl in Alzheimer's disease. Preliminary evidence for behavioral change with monoamine oxidase B inhibition. Arch Gen Psychiatry 1987; 44: 427–33
   PubMed Web of Science ®Google Scholar
• Mangoni A, Grassi M P, Frattola L, Piolti R, Bassi S, Motta A, et al. Effects of a MAO-B inhibitor in the treatment of Alzheimer's disease. Eur Neurol 1991; 31: 100–7
   PubMed Web of Science ®Google Scholar
• Burke W J, Ranno A E, Roccaforte W H, Wengel S P, Bayer B L, Willcockson N K. L-deprenyl in the treatment of mild dementia of the Alzheimer's type. J Am Ger Soc 1993; 41: 367–70
   PubMed Web of Science ®Google Scholar
• Salo P T, Tatton W G. Deprenyl reduces the death of motorneurons caused by axotomy. J Neurosci Res 1992; 31: 394–400
   PubMed Web of Science ®Google Scholar